Drugs / A01
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03474861 | Apr 2018 → Apr 2019 | digestive system cancer | Hangzhou Converd Co., Ltd. | Unknown | No outcome recorded |
| Phase 1 | NCT03472352 | Apr 2018 → Apr 2019 | cancer | Hangzhou Converd Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03472352 ↗ |